How to Buy Aytu Biopharma Stock
Aytu Biopharma Inc
Aytu Biopharma, Inc. , a specialty pharmaceutical company, focuses on developing and commercializing novel therapeutics and consumer healthcare products the United States and internationally.
Aytu Biopharma stock last closed at $2.40, down 1.64% from the previous day, and has decreased 8.05% in one year. It has overperformed other stocks in the Drug Manufacturers - Specialty & Generic industry by 0.61 percentage points. Aytu Biopharma stock is currently +152.63% from its 52-week low of $0.95, and -15.79% from its 52-week high of $2.85.
At the moment, there are 6.17M shares of AYTU outstanding. The market value of AYTU is $14.81M. In the last 24 hours, 87,000 AYTU shares were traded.
How to Buy Aytu Biopharma Stock
Not sure how to invest in Aytu Biopharma stock? Here's how.
- Choose where to buy Aytu Biopharma stock: You need to decide on a stock brokerage, but don't worry - we've tested dozens of stock brokerages and apps to help you figure out where to buy Aytu Biopharma stock.
- Open a brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've found.
- Deposit money your brokerage account: Pick your payment method and add your details.
- Evaluate Aytu Biopharma stock: The Aytu Biopharma ticker symbol is AYTU. Is Aytu Biopharma stock a good investment? Should you buy shares of AYTU? How do AYTU's underlying business fundamentals look? Do top analysts think Aytu Biopharma is a good buy? Why has AYTU's stock price moved recently? (Hint: Our stock market analysis website can help you figure out if AYTU is a good stock to buy).
- Place your AYTU buy order: Decide if you will purchase AYTU shares at the current market price or use a limit order to buy AYTU shares at a given price.
- Get notifications regarding your investment in AYTU: Create a watchlist to important notifications about your investment in Aytu Biopharma stock.
Step 1: Choose where to buy Aytu Biopharma stock
You need a brokerage account to access the NASDAQ market and buy AYTU shares.
Our preferred brokerage: eToro
Based on our experience, eToro is the best place to buy stocks. Here's why:
- Invest in stocks with 0% commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still invest in the stock.
- Access to global markets: From Tech to Real Estate, New York to Shanghai (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's top exchanges.
- Social investing: eToro offers a community with more than 20 million users around the world. Talk to, learn from, and copy the crypto trades of other investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other assets: Such as ETFs and cryptocurrencies.
Get $10 towards your stock purchase by opening an account with eToro now. This offer is only for US users.
Open eToro AccountStep 2: Open a brokerage account
Now that you've chosen the best brokerage, it's time to fill out some personal info so you are able to invest in AYTU stock today.
How to Create a New Investment Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Provide your personal data to start a new trading account.
- Send your details by hitting the "Create Account" button. Get started with eToro today
Step 3: Deposit money your brokerage account
Now that you've filled out your info on one of the best stock market apps, you need to deposit funds:
Watch the video below if you need help transferring funds into your new investment account.
Step 4: Evaluate Aytu Biopharma stock
After you have selected the best place to buy Aytu Biopharma stock, it's absolutely critical to evaluate their stock prior to buying, so you actually understand the risk and upside.
Aytu Biopharma Metrics
Fundamentals of AYTU
WallStreetZen was built to help part-time investors do more in-depth fundamental analysis quickly.
You can view all of the due diligence checks on AYTU's stock page.
Is AYTU stock properly valued?
Investors use a variety of different financial metrics, analyses, models, and charts to gauge AYTU's intrinsic value.
Using relative valuations ratios:
- AYTU may be undervalued based on its P/E ratio of 12x, relative to Drug Manufacturers - Specialty & Generic industry P/E ratio of -20.48x
- AYTU could be undervalued based on its P/B ratio of 0.42x, relative to Drug Manufacturers - Specialty & Generic industry P/B ratio of 2.13x
You can do more valuation analysis on AYTU's stock here.
Is AYTU a healthy company?
Signs that AYTU is financially healthy:
- AYTU profit margin has gone up from -16.8% to 2.4% in the past year.
- There are more short-term assets than long-term liabilities on the AYTU balance sheet.
- AYTU has cash burn of 5071000. It has sufficient cash and short-term investments to cover this for at least one year.
- AYTU has $18.17M in cash and short term investments. This is sufficient to cover its annual cash burn of $5.07M.
- There are more short-term assets than short-term liabilities on the AYTU balance sheet.
Signs that AYTU is not financially healthy:
- Total AYTU debt is higher than 5 years ago, relative to shareholder equity.
- AYTU has a relatively high debt to equity ratio of 2.56.
Is it a good time to buy AYTU stock, according to analysts?
Out of 2 sell side analysts who monitor AYTU, the consensus analyst rating on AYTU is a Strong Buy
Please keep in mind that analyst forecasts are not stock recommendations, nor are they investment advice.
You can dive deeper into what analysts are saying on the Aytu Biopharma stock forecast page.
AYTU Momentum
Is AYTU Making Money?
Last year, AYTU revenue was $69.22M. In the last five year, AYTU's revenue has grown by 36.73% per year. This was faster than the Drug Manufacturers - Specialty & Generic industry average of 9.72%.
You can research AYTU's earnings and revenue performance here.
Latest Insiders Trades at AYTU
Over the past year, executives and large shareholders at AYTU have bought more shares than they have sold.
Jarrett Disbrow, Chief Business Officer of AYTU, was the latest AYTU insider to buy. They bought $24,999.00 worth of AYTU shares on Jun 9, 2025.
Research more about who owns AYTU shares here.
Does AYTU provide a stable income stream?
No, Aytu Biopharma doesn't provide an income stream by paying out dividends.
What others are saying about AYTU
One of the primary reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to find out what other investors have to say.
Step 5: Place your AYTU buy order
There are two main options:
- Market order: A market order is an order to buy or sell a security at the best available price.
Market orders are usually the best for newer investors. - Limit order: A limit order allows you to buy or sell a security at a specific price (or better).
If you want to ensure you're buying or selling at a specific dollar amount limit, use a limit order.
Press the Open button and eToro will execute the order.
If you require additional assistance investing in stocks on eToro, click the helpful video below:
Step 6: Get notifications regarding your investment in AYTU
Now that you own some AYTU shares, you'll want to keep up with your shares.
Create a watchlist to monitor your AYTU stock.
AYTU Feed
How to Buy Stock in Aytu Biopharma
To reiterate, here are the 6 steps for buying Aytu Biopharma stock:
- Choose where to buy Aytu Biopharma stock
- Open a brokerage account
- Deposit money your brokerage account
- Evaluate Aytu Biopharma stock
- Place your AYTU buy order
- Get notifications regarding your investment in AYTU
If you need a online brokerage, eToro is our recommended venue.
Get Started with eToro TodayIf you would like to get the latest scoop on your new investment in Aytu Biopharma, add AYTU to your watchlist by clicking the button below.
Trending "How To" Guides
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.